30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)-Reference-Cited by-同舟云学术

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

Published:2023-02 Issue: Volume:137 Page:106248
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Haller T.J.,Yin X.L.,O'Byrne T.J.,Moore E.J.,Ma D.J.,Price K.P.,Patel S.H.,Hinni M.L.,Neben-Wittich M.A.,McGee L.A.,Price D.L.,Janus J.R.,Kasperbauer J.K.,Nagel T.H.,Routman D.M.,Lester S.C.,Rwigema J.C.M.,Chintakuntlawar A.V.,Savvides P.S.,Garcia J.J.,Foote R.L.,Van Abel K.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference55 articles.

1. Human Papillomavirus-Associated Cancers - United States, 2008–2012;Viens;MMWR Morb Mortal Wkly Rep,2016

2. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States;Mahal;Cancer Epidemiol Biomarkers Prev,2019

3. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. Jun 2015;107(6):djv086. doi:10.1093/jnci/djv086.

4. Oropharyngeal cancer treatment: the role of transoral surgery;Hinni;Curr Opin Otolaryngol Head Neck Surg,2015

5. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes;Choby;JAMA Otolaryngol Head Neck Surg,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know;Healthcare;2024-05-14

2. The role of surgery and deescalation for HPV‐related oropharyngeal cancer;Cancer;2024-03-18

3. Treatment Complications Associated With Hospital Admission in Oropharyngeal Cancer Patients;Nursing Research;2024-03-06

4. Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01);International Journal of Radiation Oncology*Biology*Physics;2024-01

5. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma;JAMA Otolaryngology–Head & Neck Surgery;2023-12-28